Atlas Trials

Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders

Clinical trial NCT02324673 · COMPLETED

Trial details

NCT number
NCT02324673
Sponsor
INSYS Therapeutics Inc
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Seizures
Start date
2015-04-13
Primary completion
2016-05-09
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.